— Know what they know.
Not Investment Advice

ALX NYSE

Alexander's, Inc.
1W: +3.8% 1M: -0.1% 3M: -4.9% YTD: +16.0% 1Y: +8.2% 3Y: +69.9% 5Y: +26.6%
$248.39
-2.07 (-0.83%)
 
Weekly Expected Move ±3.1%
$233 $240 $248 $256 $263
NYSE · Real Estate · REIT - Retail · Tech Score Buy · Power 61 · $1.3B mcap · 2M float · 1.76% daily turnover · Short 69% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
0.00
Neutral
0 bullish 0 neutral 0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish 0 neutral 0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (40)
Crown Castle (CCI) Tops Q3 FFO Estimates
Bullish Zacks · 6d ago · 0.90
5,300 Shares in Alexander’s, Inc. $ALX Purchased by Hsbc Holdings PLC
Bullish DefenseWorld · 6w ago · 0.90
Bank of New York Mellon Corp Invests $4.51 Million in Alexander’s, Inc. $ALX
Bullish DefenseWorld · 7w ago · 0.90
Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?
Zacks · 9w ago · 0.00
Best Momentum Stocks to Buy for August 11th
Bullish Zacks · 11w ago · 0.90
New Strong Buy Stocks for August 11th
Bullish Zacks · 11w ago · 0.90
Best Income Stocks to Buy for August 11th
Bullish Zacks · 11w ago · 0.90
Alexander's (ALX) Upgraded to Strong Buy: Here's Why
Bullish Zacks · 11w ago · 0.90
Are Finance Stocks Lagging Northern Trust (NTRS) This Year?
Zacks · 11w ago · 0.00
Alexander's (ALX) Beats Q2 FFO and Revenue Estimates
Bullish Zacks · 12w ago · 0.90
Alexander’s Announces Second Quarter Financial Results
GlobeNewsWire-EarningsResults · 12w ago · 0.00
Alexander's (ALX) Q1 2026 Earnings Transcript
MotleyFool · 24w ago · 0.00
Alexander's (ALX) Q1 2025 Earnings Transcript
MotleyFool · 24w ago · 0.00
Alexander's (ALX) Q1 FFO and Revenues Lag Estimates
Bearish Zacks · 25w ago · -0.90
Alexander's Announces First Quarter Financial Results
Benzinga-Earnings · 25w ago · 0.00
Alexander’s Announces First Quarter Financial Results
GlobeNewsWire-EarningsResults · 25w ago · 0.00
Earnings Scheduled For May 4, 2026
Bearish Benzinga-Earnings · 25w ago · -0.90
Alexander's declares $4.50 dividend
Bullish SeekingAlpha · 25w ago · 0.90
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Bullish Benzinga-News · 25w ago · 0.90
Alexander's Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
Benzinga-News · 27w ago · 0.00
SG Americas Securities LLC Has $2.39 Million Position in Alexander’s, Inc. $ALX
Bullish DefenseWorld · 29w ago · 0.90
Alexander’s to sell Rego Park I for net proceeds of $202M
Bearish SeekingAlpha · 33w ago · -0.90
Alexander's to Sell Rego Park I for Net Proceeds of $202 Million
Bearish Benzinga-News · 33w ago · -0.90
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
GlobeNewsWire · 34w ago · 0.00
Alexander's (ALX) Upgraded to Buy: Here's What You Should Know
Bullish Zacks · 34w ago · 0.90
Are Finance Stocks Lagging Alexander's (ALX) This Year?
Zacks · 35w ago · 0.00
Alexander’s (NYSE:ALX) Stock Price Down 16.4% After Earnings Miss
Bearish DefenseWorld · 37w ago · -0.90
Alexander's (ALX) Misses Q4 FFO and Revenue Estimates
Bearish Zacks · 37w ago · -0.90
Alexander's Announces Fourth Quarter Financial Results
GlobeNewsWire · 37w ago · 0.00
Is Alexander's (ALX) Stock Outpacing Its Finance Peers This Year?
Zacks · 37w ago · 0.00
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Bullish GlobeNewsWire · 37w ago · 0.90
ALX Oncology Announces Pricing of Underwritten Offering
Bullish GlobeNewsWire · 38w ago · 0.90
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
GlobeNewsWire · 38w ago · 0.00
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewsWire · 41w ago · 0.00
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
Bullish GlobeNewsWire · 41w ago · 0.90
Alexander's Completes Restructuring of Retail Loan at 731 Lexington Avenue
GlobeNewsWire · 43w ago · 0.00
Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened
Bullish DefenseWorld · 43w ago · 0.90
Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened
Bullish DefenseWorld · 44w ago · 0.90
Alexander's: Fed Tailwinds Drive FFO Growth
Bullish SeekingAlpha · 44w ago · 0.90
Alexander's Completes $175 Million Refinancing of Rego Park II
Bullish GlobeNewsWire · 46w ago · 0.90

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms